Exhibit Hall Theater
.png)
Researchers face significant challenges when working with human stem cells, including genomic abnormalities, cell line authentication issues, and bacterial contamination. These factors not only compromise the safety and reliability of research results, but also affect the overall reputation of the field. In response to these concerns, the ISSCR has issued guidelines aimed at mitigating these risks, as outlined in the “Standards for the Use of Human Stem Cells in Research”, published in June 2023.
To address these challenges, we offer a comprehensive solution. Our one-stop shop provides fast genomic integrity testing, cell line authentication, and mycoplasma detection services throughout the cell culture lifecycle.
Our 3-in-1 offering includes:
• The iCS-digital™ range, a digital PCR-based karyotyping assay that detects recurrent abnormalities in human stem cell lines (hPSCs, hMSCs and other stem cell types).
• STR (Short Tandem Repeat) testing is used to verify the identity of your cell line.
• The Myco-digital test, specifically designed to target several mycoplasma genomes.
Our fast, standard service delivers results in as little as 3 days and we provide comprehensive yet simple reports that can be easily understood. In summary, our one-stop shop solution offers unparalleled convenience, quality, and support for scientists. Experience the difference today and unlock the full potential of your research.